Edition:
India

Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

132.50INR
18 Oct 2019
Change (% chg)

Rs1.80 (+1.38%)
Prev Close
Rs130.70
Open
Rs130.90
Day's High
Rs134.95
Day's Low
Rs130.50
Volume
783,061
Avg. Vol
939,380
52-wk High
Rs314.70
52-wk Low
Rs112.30

Latest Key Developments (Source: Significant Developments)

Sun Pharma Advanced Research Gets Orphan Drug Designation From USFDA For SCO-088
Monday, 8 Jul 2019 

July 8 (Reuters) - Sun Pharma Advanced Research Company Ltd ::GETS ORPHAN DRUG DESIGNATION FROM USFDA FOR SCO-088 FOR TREATMENT OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA.  Full Article

Sun Pharma Advanced Research Says USFDA Accepted Co's NDA For Taclantis
Monday, 1 Jul 2019 

July 1 (Reuters) - Sun Pharma Advanced Research Company Ltd ::USFDA ACCEPTED FOR REVIEW SPARC’S NEW DRUG APPLICATION FOR TACLANTIS.  Full Article

Hitgen And Sparc Enter Dna-Encoded Library Based Innovative Drug Discovery Research Collaboration
Wednesday, 13 Mar 2019 

March 12 (Reuters) - :HITGEN AND SPARC ENTER DNA-ENCODED LIBRARY BASED INNOVATIVE DRUG DISCOVERY RESEARCH COLLABORATION.  Full Article

Sun Pharma Advanced Research Says Sun Pharma Global FZE Plans To Not Launch Elepsiatm XR
Friday, 15 Feb 2019 

Feb 15 (Reuters) - Sun Pharma Advanced Research Company Ltd ::SUN PHARMA ADVANCED RESEARCH COMPANY LTD - RECEIVED COMMUNICATION FROM SUN PHARMA GLOBAL FZE (SPGFZE), ABOUT PLANS TO NOT LAUNCH ELEPSIATM XR.SUN PHARMA ADVANCED RESEARCH COMPANY LTD - SPGFZE HAS DECIDED TO RETURN PRODUCT RIGHTS BACK TO CO.SUN PHARMA ADVANCED RESEARCH COMPANY LTD - CO WILL FIND ANOTHER PARTNER FOR COMMERCIALISING ELEPSIATM XR.  Full Article

Sun Pharma Advanced Research Gets Demand Notice For Assessment Yr 2014-15
Friday, 23 Feb 2018 

Feb 23 (Reuters) - Sun Pharma Advanced Research Company Ltd ::GOT DEMAND NOTICE' FOR PAYMENT OF A SUM OF 273 MILLION RUPEES FOR ASSESSMENT YEAR 2014-15.SAYS CO WOULD FILE APPROPRIATE APPEAL AGAINST INCOME TAX ORDER.  Full Article